Align Technology appoints new EVP for manufacturing, shares drop 4.1%

Align Technology, Inc. has appointed Emory Wright as the Executive Vice President of the Direct Fabrication Manufacturing Platform, effective immediately. This transition will allow Mr. Wright to focus on scaling Align’s next generation direct fabrication manufacturing platform, as he plans to retire in 2026. In addition, Srini Kaza has been promoted to Executive Vice President, Research and Development, and Dr. Mitra Derakhshan has taken on the newly created role of Executive Vice President, Chief Clinical Officer, Global Treatment Planning and Clinical Services.

Following these appointments, Align Technology President and CEO, Joe Hogan, commented that Emory Wright will lead the development of their direct 3D printing capabilities and focus on building a world-class direct fabrication operation to support the global demand for their next generation products and services. Srini Kaza, who recently celebrated his 25th anniversary with Align, will continue to lead the company's next phase of innovation, especially in light of the recent acquisition of Cubicure, where they are pioneering the next generation of 3D printing technologies.

Dr. Mitra Derakhshan, who has been with Align for over 23 years, will create an end-to-end global treatment planning and clinical services organization by combining the global treat operations and global clinical teams. This combination is aimed at driving increased confidence and adoption of the Invisalign system globally.

Jitse Marree, with over 20 years of experience in the medical device, healthcare, and food industries, has expanded his existing position as Vice President, Global Aligner Manufacturing Operations to include global clear aligner operations.

Align Technology, Inc. also highlighted that over the past 27 years, they have helped doctors treat over 17.6 million patients with the Invisalign system and are driving the evolution in digital dentistry through their integrated suite of proprietary technologies and services.

In terms of financial metrics, it is important to note that the press release focuses primarily on executive appointments and the strategic direction of the company, rather than specific financial figures. Today the company's shares have moved -4.1% to a price of $250.47. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.